Maxim Group lowered shares of Biocept (NASDAQ:BIOC – Get Rating) from a buy rating to a hold rating in a research report report published on Friday, The Fly reports. BIOC has been the topic of several other research reports. StockNews.com started coverage on shares of Biocept in a research note on Wednesday, April 12th. They […]
Biocept Inc (NASDAQ:BIOC), which develops and commercializes molecular diagnostic assays, revealed new details about its plans to get its CNSide assay.
Biocept, Inc. , a leading provider of molecular diagnostic assays, products and services, reports financial results for the 12 months ended December 31, 2022 and provides a business. | April 17, 2023
StockNews.com initiated coverage on shares of Biocept (NASDAQ:BIOC – Get Rating) in a report published on Tuesday. The firm issued a hold rating on the medical research company’s stock. Separately, Brookline Capital Management downgraded shares of Biocept from a buy rating to a hold rating in a research report on Friday, January 6th. Biocept Stock […]